Form 8-K - Current report:
SEC Accession No. 0001104659-25-022425
Filing Date
2025-03-11
Accepted
2025-03-11 08:07:20
Documents
15
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258725d1_8k.htm   iXBRL 8-K 28376
2 EXHIBIT 99.1 tm258725d1_ex99-1.htm EX-99.1 59888
6 GRAPHIC tm258725d1_ex99-1img01.jpg GRAPHIC 6242
  Complete submission text file 0001104659-25-022425.txt   281587

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20250311.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20250311_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20250311_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT tm258725d1_8k_htm.xml XML 3691
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 25725907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)